November 9, 2022
Via: PharmaphorumThe alliance is backloaded, with $21.5 million paid upfront and Insilico also in line for mid-single to up to low double-digit tiered royalties for any products developed, but it is comfortably the Chinese company’s largest deal to date. “This collaboration […]
October 14, 2022
Via: Contract PharmaGamma Biosciences, a provider of tools and technologies for cell and gene therapy manufacturing, through their BioMagnetic Solutions business, entered a strategic collaboration with Lonza. Under the multi-year agreement, BioMagnetic Solutions will supply its research and cGMP manufacturing grade FerroSelect […]
October 14, 2022
Via: Contract PharmaShowa Denko Materials Co., Ltd. and Kidswell Bio Corp. have entered an agreement to enable process development and clinical manufacturing of cell therapy products using the advantage of SHED*2 (Stem cells from Human Exfoliated Deciduous teeth) which is under development […]
September 30, 2022
Via: Contract PharmaVanda Pharmaceuticals Inc. and OliPass Corp. have entered into a research and development collaboration to jointly develop a set of antisense oligonucleotide (ASO) molecules based on OliPass’ modified peptide nucleic acids. The partnership leverages the respective strengths of Vanda and […]
July 11, 2024
July 11, 2024
July 19, 2024
Copyright © 2024. All rights reserved
